 <div id="USH3A_desc" class="disease_desc" style="width: 77%;">
         <h2  class="dis_title"><IMG class="dis_dna" src="img/dna_vert_med.png" align="middle"/>USH3A</h2>
<h3 class="dis_subtitle">Usher syndrome, type III A</h3>

<div class="container dis_desc2"> 

<h4  style="color: #000000;">Genes associated with this disease:</h4>
<li>  <a href="lovd2_CLRN1.html?gene=CLRN1&name=Clarin&ensemb=ENSG00000163646&disease=USH3A&omim=276902&exturl=https://grenada.lumc.nl/LOVD2/Usher_montpellier/home.php?select_db=CLRN1&extsrc=https://grenada.lumc.nl/LOVD2/Usher_montpellier/home.php?select_db=CLRN1&extsrctitle=Retinal%20and%20hearing%20impairment%20genetic%20mutation%20database&curator=David%20Baux&ncbi=7401">Clarin (CLRN1)</a> </li>
</div>
<br/>
<div class="container dis_desc2">

Usher syndrome (USH) is an autosomal recessive disease characterized by sensorineural hearing loss, progressive retinal degeneration and variable vestibular dysfunction depending on the subtype. 

<br/><br/> 

Three major subtypes of Usher syndrome are USH1, USH2 and USH3:

<br/><br/> 

Type 3A Usher syndrome (USH3A) is enriched in the Finnish population, where it accounts for 40% of all Usher cases. USH3A is caused by mutations in CLRN1 and most Finnish USH3A patients are homozygous for the Finnish founder mutation p.(Tyr176*). Mutations in the CLRN1 gene also cause Retinitis pigmentosa 61 (OMIM#614180).

<br/><br/> 
The second USH3 subtype, USH3B (614504) is caused by a homozygous mutation in the histidyl-tRNA synthetase gene (HARS;OMIM# 142810), but the mutation has only been found in three Old Order Amish Usher patients.

<br/><br/> 

In addition to USH3A, USH1 is found in 34%, and USH2 in 12%, of Finnish USH patients. Mutations in other genes than CLRN1 are known to cause the USH1 and 2 subtypes: 

<br/><br/> 

USH1 is caused by mutations in:
<br/><br/> 
<li> MYO7A (USH1B)</li>
<li> harmonin (USH1C)</li>
<li> CDH23 (USH1D)</li>
<li> PCDH15 (USH1F)</li>
<li> SANS (USH1G)</li>
<li> CIB2 (USH1J)</li>
<br/>

USH2 results from mutations in:
<br/><br/> 
<li> usherin (USH2A)</li>
<li> GPR98 (USH2C)</li>
<li> WHRN (USH2D)</li>
<br/><br/> 

The clinical features of USH3A include postlingual hearing impairment, which usually develops by the age of eight years. The hearing loss is progressive, sensorineural, and cochleal, resulting in moderate to severe deafness within a few years or decades. Patients have either normal or decreased vestibular function.

<br/><br/> 

Retinal manifestation, retinitis pigmentosa, is diagnosed at the mean age of 17 years. The symptoms of night blindness, followed by mid peripheral visual field defects, lead to narrowed visual fields and slowly progressive tunnel vision at a mean age of 30 years. The progression of RP results in a severe visual handicap. 

<br/><br/> 

Diagnosis of USH3A on clinical findings can be confirmed by gene tests, which also allow carrier identification.

  <br>
  </div>

<br/>

<div class="container dis_desc2">

<h4  style="color: #000000;">Selected References:</h4>

<li> 
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12080385" target="_blank">Joensuu 2001</a> 
<br/>

<li> 
<a href="http://www.ncbi.nlm.nih.gov/pubmed/22681893" target="_blank">Vastinsalo 2012</a>

<br/>

      <span class="" style="float: right;"><b><a href="diseases.html"><img src="img/disease.png" height="25" width="25" style="position: relative; top: -4;left: -4;"></a></b></span>
</div>

<br/>

<div class="container dis_desc2">

  <h4  style="color: #000000;">More information:</h4>
    <li> <a href="pub.html?disease=USH3" target="_blank">USH3A Publications</a>
    <li> <a href="http://omim.org/entry/276902" target="_blank">Omim disease entry</a>
<br/>
      <span class="" style="float: right;"><b><a href="diseases.html"><img src="img/disease.png" height="25" width="25" style="position: relative; top: -4;left: -4;"></a></b></span>
</div>
   
     <br/>
    </div>
  </div>
